blank LMU Munich Faculty for Chemistry and Pharmacy
print
 

ERC Project

Under the ERC Starting Grant ERC-2014-StG – 637830 "Novel Asthma Therapy" we are developing dry powder platform technologies for pulmonary delivery of siRNA for targeting activated T cells in the lung.

https://erc.europa.eu/projects-and-results/erc-funded-projects/novel-asthma-therapy

http://cordis.europa.eu/project/rcn/198156_en.html

Our project has a clear potential of advancing pulmonary nanomedicine as novel asthma therapy.

Project-related publications: